Brendan Saloner, PhD, is the Donald G. Millar Professor of Alcohol and Addiction Studies in the Department of Health Services, Policy, and Practice. One strand of his research focuses on access and quality of care for people with mental health and substance use disorders. He has received funding awards from the National Institute on Drug Abuse (NIDA) and Arnold Ventures to study opioid use disorder treatment, including recent grants to study the implementation of mobile methadone treatment in New York state and urine drug testing for patients with opioid use disorder. At Johns Hopkins, he co-led the evaluation team for the Bloomberg Overdose Prevention Initiative, a $120 million investment in overdose reduction focused on seven states.
A second strand of his research focuses specifically on health care for people in the criminal legal system. He has also received grants from NIDA and Arnold Ventures to investigate medications for opioid use disorder among incarcerated people. He is currently evaluating the statewide expansion of addiction treatment in Maryland county detention facilities. Finally, Professor Saloner maintains an active research program in bioethics. He led a Making a Difference grant supported by the Greenwall Foundation to study resource allocation in jails and prisons during the COVID-19 pandemic. He received the Greenwall Faculty Scholars Award in 2023 for a project focused on ethical issues related to mandated addiction treatment for people in the criminal legal system. Professor Saloner has an extensive interest in policy engagement. He has testified in the U.S. Senate, consulted with federal and state agencies, and has engaged in technical assistance projects.
Professor Saloner received his BA from the University of California, Berkeley and his PhD in Health Policy from Harvard University (ethics concentration). He was a Robert Wood Johnson Health and Society Scholar at the University of Pennsylvania.
| Cook BL, Flores M, Progovac AM, Moyer M, Holmes KE, Lê T, Kumar A, Levy D, Saloner B, Wayne GF. "Association of Tobacco Dependence Treatment Coverage Expansion With Smoking Behaviors Among Medicaid Beneficiaries Living With Substance Use Disorder." American Journal of Preventive Medicine, vol. 68, no. 3, 2025, pp. 485-496. |
| Stein BD, Saloner BK, Sheng F, Sorbero M, Dick AW, Gordon AJ. "Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic : State Telehealth Policies and Buprenorphine." J GEN INTERN MED, vol. 40, no. 9, 2025, pp. 1986-1994. |
| Feder KA, Li Y, Burke KN, Byrne L, Desai IK, Saloner B, Krawczyk N. "Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data." Journal of substance use and addiction treatment, vol. 168, 2025, pp. 209545. |
| Stein BD, Sheng F, Saloner BK, Gordon AJ, Merlin JS. "Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl." Addiction Science & Clinical Practice, vol. 20, no. 1, 2025, pp. 33. |
| Saloner B, Heller D, Davis CS, Sherman SG. "Harm Reduction: The Neglected Pillar of US Drug Policy." Annual review of public health, vol. 46, no. 1, 2025, pp. 369-387. |
| Sugarman OK, Saloner B, Harris SJ, Irvin R, Flanagan V, Bandara S. "Hepatitis C Treatment in Kentucky Medicaid Recipients with Concurrent Opioid Use Disorder: A Cross-Sectional Study." J GEN INTERN MED, 2025. |
| Bandara S, Saloner B, Maniates H, Song M, Krawczyk N. "Implementation of carceral medicaid suspension and enrollment programs: perspectives of carceral and medicaid leaders." Health & Justice, vol. 13, no. 1, 2025, pp. 1. |
| Lenz C, Song M, Bandara S, Kennedy Hendricks A, Kramer C, Sufrin C, Fingerhood M, Saloner B. "Implementation of Jail and Prison-Based Medication Treatment for Opioid Use Disorder Programs: A Narrative Synthesis." Medical Care Research and Review, 2025, pp. 10775587251345018. |
| Li W, Eisenberg M, Song M, Kennedy-Hendricks A, Saloner B. "Medications for Opioid Use Disorder After Entering Residential Treatment: Evidence From Louisiana Medicaid." Journal of Addiction Medicine, vol. 19, no. 1, 2025, pp. 47-52. |
| Heidari O, Sugarman OK, Winiker AK, Gattine S, Flanagan V, Razaghi R, Saloner BK. "Personal Experiences With Xylazine and Behavior Change: A Qualitative Content Analysis of Reddit Posts." Journal of Addiction Medicine, vol. 19, no. 2, 2025, pp. 135-142. |
| Reid MC, Harris SJ, Grieb SM, Gattine S, Lukco Z, Hool B, Aguirre M, Aranda FA, Tomko C, Whaley S, Saloner B, Allen ST. "Perspectives of syringe services program operators in Michigan on their relationship with substance use treatment: a qualitative study." Harm Reduction Journal, vol. 22, no. 1, 2025, pp. 25. |
| Taylor J, Bandara S, Thomas CP, Saloner B, Fredericks PJ, Shen K. "Predictors of non-transport by emergency medical services after a nonfatal opioid overdose: a national analysis." Health affairs scholar, vol. 3, no. 5, 2025, pp. qxaf101. |
| Saloner B, Bandara S, Kennedy-Hendricks A. "Stable, But Weak: Fifty Years of U.S. Illicit Drug Policy from Nixon to Trump and Beyond." Journal of Health Politics, Policy and Law, 2025. |
| Kramer C, Lenz C, Song M, Sufrin C, Kennedy-Hendricks A, Fingerhood M, Bandara SN, Saloner B. "State-Mandated Opioid Use Disorder Treatment In Maryland Jails Helped Patients Recover Despite Gaps In Care." Health Affairs, vol. 44, no. 5, 2025, pp. 614-621. |
| Saloner B. "The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward." The Milbank Quarterly, 2025. |
| Sugarman OK, Shah H, Whaley S, McCourt A, Saloner B, Bandara S. "A content analysis of legal policy responses to xylazine in the illicit drug supply in the United States." International Journal of Drug Policy, vol. 129, 2024, pp. 104472. |
| Doan B, Kramer C, Saloner B, Song M, Sufrin CB, Rubenstein LS, Eber GB. "Allocating health care resources in jails and prisons during COVID-19: a qualitative study of carceral decision-makers." Health affairs scholar, vol. 2, no. 4, 2024, pp. qxae015. |
| Lyle V, Harris S, Heidari O, Boulton K, Hulsey E, Saloner B, Gibbons J. "Association between high-threshold practices and buprenorphine treatment termination." International Journal of Drug Policy, vol. 124, 2024, pp. 104318. |
| Sugarman OK, Saloner B, Richards TM, Lasser EC, Heath T, Idries S, Weiner JP, Bandara S. "Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases." Drug and Alcohol Dependence, vol. 258, 2024, pp. 111281. |
| Feder KA, Byrne L, Miller SM, Sodder S, Saloner B. "Beliefs and Attitudes about Vermont's Buprenorphine Decriminalization Law among Clinicians Who Prescribe Buprenorphine." Substance Use & Misuse, vol. 59, no. 1, 2024, pp. 150-153. |
| Heidari O, Shah H, Bhagwat A, Ahmad NJ, Whaley S, Sherman SG, Morris M, Saloner B. "Changes in opioid treatment programs and harm reduction provider services during the COVID-19 pandemic: Findings from 10 states." Psychological Services, vol. 21, no. 3, 2024, pp. 658-664. |
| Saloner B, Blumenthal-Barby J. "Coercion, Power Relations, and the Expectations Patients Bring to Mental Health Treatment." The American journal of bioethics : AJOB, vol. 24, no. 12, 2024, pp. 6-7. |
| Donahoe JT, Donohue JM, Saloner BK. "Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment." JAMA Health Forum, vol. 5, no. 9, 2024, pp. e242807. |
| Blumenthal-Barby J, Fletcher FE, Taylor L, Nelson RH, Moore B, Saloner B, Ubel PA. "Ethical Complexities in Utilizing Artificial Intelligence for Surrogate Decision Making." The American journal of bioethics : AJOB, vol. 24, no. 7, 2024, pp. 1-2. |
| Saloner B, Sugarman OK, Byrne L, Harris S, Reid MC, Shah H, Hulsey E, Hurst A, Kerins L, King D, Sherman S, Kaner E, Heller D, Bandara S. "Experiences of the changing illicit drug supply among racial and ethnic minoritized people in three US states: a qualitative study." Harm Reduction Journal, vol. 21, no. 1, 2024, pp. 205. |
| Schuler MS, Dick AW, Gordon AJ, Saloner B, Kerber R, Stein BD. "Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018." Drug and Alcohol Dependence, vol. 259, 2024, pp. 111290. |
| Bandara S, Byrne L, Berman V, Hurst A, King D, Gibbons JB, Sugarman OK, Livingston A, Kerins L, Hulsey EG, Alves A, Saloner B. "Harm Reduction and Treatment Among People at High Risk of Overdose." JAMA Network Open, vol. 7, no. 8, 2024, pp. e2427241. |
| Sugarman OK, Harris SJ, Byrne L, Flanagan V, Gattine S, Desai I, Heidari O, Gibbons JB, Whaley S, Lucas D, Pugh T, McBride A, Saloner B. "How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky." Addiction Science & Clinical Practice, vol. 19, no. 1, 2024, pp. 78. |
| Harris SJ, Golberstein E, Maclean JC, Stein BD, Ettner SL, Saloner B. "Implementation Of New Mexico's 'No Behavioral Health Cost Sharing' Law: A Qualitative Study." Health Affairs, vol. 43, no. 10, 2024, pp. 1448-1454. |
| Turnbull AE, Bouhassira DC, Saloner B. "Incapacitated and Incarcerated-Double Barriers to Care." JAMA Internal Medicine, vol. 184, no. 1, 2024, pp. 35-36. |
| Kennedy-Hendricks A, Song M, McCourt AD, Sharfstein JM, Eisenberg MD, Saloner B. "Licensure Policies May Help States Ensure Access To Opioid Use Disorder Medication In Specialty Addiction Treatment." Health Affairs, vol. 43, no. 5, 2024, pp. 732-739. |
| Sugarman OK, Li W, Saloner B. "Medications For Opioid Use Disorder Increased Among Louisiana Medicaid Enrollees During Policy Reforms, 2018-21." Health Affairs, vol. 43, no. 1, 2024, pp. 46-54. |
| Gibbons JB, Sugarman OK, Byrne L, Harris SJ, Shah H, Hulsey EG, Rwan J, Rosner EM, Pantaleo A, Bergquist E, Saloner B. "Perceptions of a naloxone leave behind program among emergency medical services personnel in Michigan, USA." Drug and alcohol dependence reports, vol. 12, 2024, pp. 100273. |
| Gibbons JB, Harris SJ, Sugarman OK, Hulsey EG, Rwan J, Rosner EM, Saloner B. "Piloting racial bias training for hospital emergency department providers treating patients with opioid use disorder." Health affairs scholar, vol. 2, no. 5, 2024, pp. qxae049. |
| Golberstein E, Campbell JM, Maclean JC, Harris SJ, Saloner B, Stein BD. "Prescription Drug Dispensing and Patient Costs After Implementation of a No Behavioral Health Cost-Sharing Law." JAMA Health Forum, vol. 5, no. 3, 2024, pp. e240198. |
| Drake C, Nagy D, Meiselbach MK, Zhu JM, Saloner B, Stein BD, Polsky D. "Racial and Ethnic Disparities in Geographic Availability of Buprenorphine." Journal of Addiction Medicine, vol. 18, no. 3, 2024, pp. 335-338. |
| Gibbons JB, Li W, Stuart EA, Saloner B. "Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder." Health Serv Res, vol. 59, no. 5, 2024, pp. e14271. |
| Green VR, Kennedy-Hendricks A, Saloner B, Bandara S. "Substance use and treatment characteristics among pregnant and non-pregnant females, 2015-2019." Drug and Alcohol Dependence, vol. 254, 2024, pp. 111041. |
| Saloner B. "The Overdose Crisis in the 2024 Election-Political Fights and Practical Problems." JAMA, vol. 331, no. 19, 2024, pp. 1621-1622. |
| Landis RK, Stein BD, Dick AW, Griffin BA, Saloner BK, Terplan M, Faherty LJ. "Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012." Medical Care Research and Review, vol. 81, no. 2, 2024, pp. 145-155. |
| McGinty EE, White SA, Eisenberg MD, Palmer NR, Brown CH, Saloner BK. "US payment policy for medications to treat opioid use disorder: landscape and opportunities." Health affairs scholar, vol. 2, no. 3, 2024, pp. qxae024. |
| Harris SJ, Landis RK, Li W, Stein BD, Saloner B. "Utilization of Medications for Opioid Use Disorder Among West Virginia Medicaid Enrollees Following Medicaid Coverage of Methadone." Substance use & addiction journal, vol. 45, no. 1, 2024, pp. 91-100. |
| Schneider KE, Martin EM, Allen ST, Morris M, Haney K, Saloner B, Sherman SG. "Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States." International Journal of Drug Policy, vol. 126, 2024, pp. 104371. |
| Song M, Kramer CT, Sufrin CB, Eber GB, Rubenstein LS, Beyrer C, Saloner B. "It was like you were being literally punished for getting sick": formerly incarcerated people's perspectives on liberty restrictions during COVID-19." AJOB empirical bioethics, vol. 14, no. 3, 2023, pp. 155-166. |
| Saloner B. "A Chance to Modernize Health Care behind Bars - Section 1115 Medicaid Inmate Exclusion Waivers." New England Journal of Medicine, vol. 389, no. 16, 2023, pp. 1449-1451. |
| Saloner B, Li W, Flores M, Progovac AM, Lê Cook B. "A Widening Divide: Cigarette Smoking Trends Among People With Substance Use Disorder And Criminal Legal Involvement." Health Affairs, vol. 42, no. 2, 2023, pp. 187-196. |
| Solomon KT, O'Connor J, Gibbons JB, Kilaru AS, Feder KA, Xue L, Saloner B, Stuart EA, Cole ES, Hulsey E, Meisel Z, Patel E, Donohue JM. "Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge." JAMA Health Forum, vol. 4, no. 3, 2023, pp. e230245. |
| Pytell JD, Whitley P, Passik SD, Bundy WL, Dawson E, Saloner B. "Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder." JAMA Psychiatry, vol. 80, no. 5, 2023, pp. 459-467. |
| Stein BD, Saloner BK, Golan OK, Andraka-Christou B, Andrews CM, Dick AW, Davis CS, Sheng F, Gordon AJ. "Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment." JAMA Health Forum, vol. 4, no. 5, 2023, pp. e231102. |
| Feder KA, Harris SJ, Byrne L, Miller SM, Sodder S, Berman V, Livingston A, Edwards J, Hartman S, Sugarman OK, Shah H, Xu J, Raikes J, Gattine S, Saloner B. "Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids." Drug and Alcohol Dependence, vol. 250, 2023, pp. 110879. |
| Stein BD, Landis RK, Sheng F, Saloner B, Gordon AJ, Sorbero M, Dick AW. "Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention." J GEN INTERN MED, vol. 38, no. 3, 2023, pp. 733-737. |
| Saloner B, Kramer C, Song M, Doan B, Eber GB, Rubenstein LS, Sufrin C. "COVID-19 Restrictions In Jails And Prisons: Perspectives From Carceral Leaders." Health Affairs, vol. 42, no. 6, 2023, pp. 841-848. |
| Kramer C, Song M, Sufrin CB, Eber GB, Rubenstein LS, Saloner B. "COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons." Vaccine, vol. 41, no. 7, 2023, pp. 1408-1417. |
| Saloner B, Chang HY, Alexander GC, Stein BD. "Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework." Medical Care, vol. 61, no. 2, 2023, pp. 95-101. |
| Landis RK, Stein BD, Griffin BA, Saloner BK, Terplan M, Faherty LJ. "Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012." Journal of Addiction Medicine, vol. 17, no. 6, 2023, pp. 654-661. |
| Curran J, Saloner B, Winkelman TNA, Alexander GC. "Estimated Use of Prescription Medications Among Individuals Incarcerated in Jails and State Prisons in the US." JAMA Health Forum, vol. 4, no. 4, 2023, pp. e230482. |
| Griffin BA, Cabreros I, Saloner B, Gordon AJ, Kerber R, Stein BD. "Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads." Substance Abuse, vol. 44, no. 3, 2023, pp. 136-145. |
| Song M, Desai IK, Meyer A, Shah H, Saloner B, Sherman SG, Allen ST, Tomko C, Schneider KE, Krawczyk N, Whaley S, Churchill J, Harris SJ. "Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study." International Journal of Drug Policy, vol. 122, 2023, pp. 104239. |
| Allen ST, Schneider KE, Morris M, Saloner B, Sherman SG. "Factors Associated with HIV Testing Among People Who Inject Drugs: Findings from a Multistate Study at the Start of the COVID-19 Pandemic." AIDS and Behavior, vol. 27, no. 5, 2023, pp. 1674-1681. |
| Allen ST, Schneider KE, Morris M, Rouhani S, Harris SJ, Saloner B, Sherman SG. "Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic." Harm Reduction Journal, vol. 20, no. 1, 2023, pp. 18. |
| Tilhou AS, Saloner B, DeLeire T, Chakraborty S, Dague L. "Health and Healthcare Access for Essential, Nonessential, and Nonworkers During the COVID-19 Pandemic." Journal of Occupational and Environmental Medicine, vol. 65, no. 11, 2023, pp. e703-e709. |
| Treitler P, Nowels M, Feder KA, Saloner B, Reeves R, DeBilio L, Crystal S. "Hospital Use and Mortality Among Decarcerated Individuals With Substance Use Disorder After a Large-scale COVID-19 Emergency Prison Release Program." JAMA Health Forum, vol. 4, no. 6, 2023, pp. e231200. |
| Harris SJ, Golberstein E, Maclean JC, Stein BD, Ettner SL, Saloner B. "How policymakers innovate around behavioral health: adoption of the New Mexico "No Behavioral Health Cost-Sharing" law." Health affairs scholar, vol. 2, no. 1, 2023, pp. qxad081. |
| Carroll G, Solomon KT, Heil J, Saloner B, Stuart EA, Patel EY, Greifer N, Salzman M, Murphy E, Baston K, Haroz R. "Impact of Administering Buprenorphine to Overdose Survivors Using Emergency Medical Services." Annals of Emergency Medicine, vol. 81, no. 2, 2023, pp. 165-175. |
| Schneider KE, Allen ST, Rouhani S, Morris M, Haney K, Saloner B, Sherman SG. "Increased solitary drug use during COVID-19: An unintended consequence of social distancing." International Journal of Drug Policy, vol. 111, 2023, pp. 103923. |
| Gibbons JB, Harris SJ, Solomon KT, Sugarman O, Hardy C, Saloner B. "Increasing overdose deaths among Black Americans: a review of the literature." The Lancet Psychiatry, vol. 10, no. 9, 2023, pp. 719-726. |
| Schuler MS, Saloner B, Gordon AJ, Dick AW, Stein BD. "National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018." Substance Abuse, vol. 44, no. 3, 2023, pp. 154-163. |
| Saloner B, Whitley P, Dawson E, Passik S, Gordon AJ, Stein BD. "Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety." Addiction, vol. 118, no. 8, 2023, pp. 1549-1556. |
| Andraka-Christou B, Golan O, Totaram R, Ohama M, Saloner B, Gordon AJ, Stein BD. "Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019." Annals of medicine, vol. 55, no. 1, 2023, pp. 514-520. |
| Kramer C, Song M, Sufrin CB, Eber GB, Rubenstein LS, Saloner B. "Release, Reentry, and Reintegration During COVID-19: Perspectives of Individuals Recently Released from the Federal Bureau of Prisons." Health Equity, vol. 7, no. 1, 2023, pp. 384-394. |
| Bono MH, Treitler P, Saloner B, Crystal S. "Returning home during the pandemic: a thematic analysis describing experiences of people with substance use disorders released early from New Jersey prisons during COVID-19." Health & Justice, vol. 11, no. 1, 2023, pp. 11. |
| Meiselbach MK, Drake C, Zhu JM, Manibusan B, Nagy D, Sorbero MJ, Saloner B, Stein BD, Polsky D. "State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care." Medical Care Research and Review, vol. 80, no. 4, 2023, pp. 423-432. |
| Andraka-Christou B, McAvoy E, Gordon AJ, Ohama M, Brach M, Taylor EA, Vaiana M, Saloner B, Stein BD. "Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022." Pain Medicine, vol. 24, no. 12, 2023, pp. 1306-1317. |
| Saloner B, Andraka-Christou B, Stein BD, Gordon AJ. "Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations Act." Substance Abuse, vol. 44, no. 3, 2023, pp. 108-111. |
| Saloner B, Landis RK, Jayakrishnan R, Stein BD, Barry CL. "A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid." Substance Abuse, vol. 43, no. 1, 2022, pp. 682-690. |
| Saloner B, Eber GB, Sufrin CB, Beyrer C, Rubenstein LS. "A Human Rights Framework for Advancing the Standard of Medical Care for Incarcerated People in the United States in the Time of COVID-19." Health and human rights, vol. 24, no. 1, 2022, pp. 59-75. |
| Andraka-Christou B, Randall-Kosich O, Golan M, Totaram R, Saloner B, Gordon AJ, Stein BD. "A national survey of state laws regarding medications for opioid use disorder in problem-solving courts." Health & Justice, vol. 10, no. 1, 2022, pp. 14. |
| Solomon KT, Bandara S, Reynolds IS, Krawczyk N, Saloner B, Stuart E, Connolly E. "Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis." Journal of Substance Abuse Treatment, vol. 132, 2022, pp. 108424. |
| Landis RK, Opper I, Saloner B, Gordon AJ, Leslie DL, Sorbero M, Stein BD. "Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies." Drug and Alcohol Dependence, vol. 241, 2022, pp. 109669. |
| Saloner B, Campbell J, Gollust S, Blewett LA. "Changes in Material Hardship During the First Year of the COVID-19 Pandemic." JAMA Health Forum, vol. 3, no. 2, 2022, pp. e215213. |
| Ferris LM, Weiner JP, Saloner B, Kharrazi H. "Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysis." JAMIA Open, vol. 5, no. 1, 2022, pp. ooac020. |
| Levin JS, Landis RK, Sorbero M, Dick AW, Saloner B, Stein BD. "Differences in buprenorphine treatment quality across physician provider specialties." Drug and Alcohol Dependence, vol. 237, 2022, pp. 109510. |
| Patel SY, Wayne GF, Progovac AM, Flores M, Moyer M, Mullin B, Levy D, Saloner B, Cook BL. "Effects of Medicaid coverage on receipt of tobacco dependence treatment among Medicaid beneficiaries with substance use disorder." Health Serv Res, vol. 57, no. 6, 2022, pp. 1303-1311. |
| Saloner B, Krawczyk N, Solomon K, Allen ST, Morris M, Haney K, Sherman SG. "Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey." International Journal of Drug Policy, vol. 101, 2022, pp. 103537. |
| Patel E, Solomon K, Saleem H, Saloner B, Pugh T, Hulsey E, Leontsini E. "Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals." Journal of Substance Abuse Treatment, vol. 136, 2022, pp. 108658. |
| Krawczyk N, Allen ST, Schneider KE, Solomon K, Shah H, Morris M, Harris SJ, Sherman SG, Saloner B. "Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs." Harm Reduction Journal, vol. 19, no. 1, 2022, pp. 95. |
| Krawczyk N, Bandara S, Merritt S, Shah H, Duncan A, McEntee B, Schiff M, Ahmad NJ, Whaley S, Latimore A, Saloner B. "Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative." Addiction Science & Clinical Practice, vol. 17, no. 1, 2022, pp. 30. |
| Andraka-Christou B, Saloner B, Gordon AJ, Totaram R, Randall-Kosich O, Golan M, Stein BD. "Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C." The American Journal of Drug and Alcohol Abuse, vol. 48, no. 4, 2022, pp. 492-503. |
| Pollack CE, Saloner B, Lucas S, Warren E, Chaubal M, Kennedy-Hendricks A. "Leveraging the Affordable Housing Sector to Respond to the Opioid Crisis." public health reports, vol. 137, no. 3, 2022, pp. 414-419. |
| Meiselbach MK, Drake C, Saloner B, Zhu JM, Stein BD, Polsky D. "Medicaid Managed Care: Access To Primary Care Providers Who Prescribe Buprenorphine." Health Affairs, vol. 41, no. 6, 2022, pp. 901-910. |
| Gibbons JB, Stuart EA, Saloner B. "Methadone on Wheels-A New Option to Expand Access to Care Through Mobile Units." JAMA Psychiatry, vol. 79, no. 3, 2022, pp. 187-188. |
| Bandara S, Maniates H, Hulsey E, Smith JS, DiDomenico E, Stuart EA, Saloner B, Krawczyk N. "Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey." BMC Health Services Research, vol. 22, no. 1, 2022, pp. 418. |
| Krawczyk N, Maniates H, Hulsey E, Smith JS, DiDomenico E, Stuart EA, Saloner B, Bandara S. "Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs." Journal of Addiction Medicine, vol. 16, no. 6, 2022, pp. 645-652. |
| Landis RK, Levin JS, Saloner B, Gordon AJ, Dick AW, Sherry TB, Leslie DL, Sorbero M, Stein BD. "Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine." Substance Abuse, vol. 43, no. 1, 2022, pp. 1057-1071. |
| Stein BD, Saloner B, Kerber R, Sorbero M, Gordon AJ. "Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020." Annals of Emergency Medicine, vol. 79, no. 5, 2022, pp. 441-450. |
| Allen L, Burns M, Saloner B. "The Consequences of Removing Prior Authorization for Buprenorphine in Medicaid-Building an Evidence Base." JAMA Health Forum, vol. 3, no. 6, 2022, pp. e220189. |
| Alinsky RH, Prichett L, Chang HY, Alexander GC, Stein BD, Saloner B. "Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic." Journal of Adolescent Health, vol. 71, no. 2, 2022, pp. 239-241. |
| Tilhou AS, Dague L, Saloner B, Beemon D, Burns M. "Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic." JAMA Health Forum, vol. 3, no. 3, 2022, pp. e220093. |
| Saloner B, Li W, Bandara SN, McGinty EE, Barry CL. "Trends In The Use Of Treatment For Substance Use Disorders, 2010-19." Health Affairs, vol. 41, no. 5, 2022, pp. 696-702. |
| Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. "Admission Practices And Cost Of Care For Opioid Use Disorder At Residential Addiction Treatment Programs In The US." Health Affairs, vol. 40, no. 2, 2021, pp. 317-325. |
| Lee D, Saloner B, Barnett M. "Advanced Practice Providers and Buprenorphine Access in the United States After the Comprehensive Addiction and Recovery Act." PS, vol. 72, no. 11, 2021, pp. 1358-1359. |
| Nguyen TD, Gupta S, Ziedan E, Simon KI, Alexander GC, Saloner B, Stein BD. "Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic." JAMA Internal Medicine, vol. 181, no. 4, 2021, pp. 562-565. |
| Nguyen TD, Saloner B, Stein BD. "Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply." JAMA Internal Medicine, vol. 181, no. 8, 2021, pp. 1135-1136. |
| Cabreros I, Griffin BA, Saloner B, Gordon AJ, Kerber R, Stein BD. "Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories." Drug and Alcohol Dependence, vol. 228, 2021, pp. 109089. |
| Stein BD, Saloner B, Schuler MS, Gurvey J, Sorbero M, Gordon AJ. "Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US." JAMA, vol. 325, no. 21, 2021, pp. 2206-2208. |
| Ward JA, Parish K, DiLaura G, Dolovich S, Saloner B. "COVID-19 Cases Among Employees of U.S. Federal and State Prisons." American Journal of Preventive Medicine, vol. 60, no. 6, 2021, pp. 840-844. |
| Marquez N, Ward JA, Parish K, Saloner B, Dolovich S. "COVID-19 Incidence and Mortality in Federal and State Prisons Compared With the US Population, April 5, 2020, to April 3, 2021." JAMA, vol. 326, no. 18, 2021, pp. 1865-1867. |
| Patel E, Bandara S, Saloner B, Stuart EA, Goodman D, Terplan M, McCourt A, White S, McGinty EE. "Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018." American Journal of Obstetrics & Gynecology MFM, vol. 3, no. 5, 2021, pp. 100419. |
| Maclean JC, Wen H, Simon KI, Saloner B. "Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment Facilities." Health Affairs, vol. 40, no. 2, 2021, pp. 326-333. |
| Saloner B, Andraka Christou B, Gordon AJ, Stein BD. "It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver." Substance Abuse, vol. 42, no. 2, 2021, pp. 153-157. |
| Krawczyk N, Garrett B, Ahmad NJ, Patel E, Solomon K, Stuart EA, Saloner B. "Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample." Drug and Alcohol Dependence, vol. 220, 2021, pp. 108512. |
| Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. "Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters." Addiction, vol. 116, no. 12, 2021, pp. 3473-3481. |
| Kane EI 3rd, Daumit GL, Fain KM, Saloner B, Scherer RW, McGinty EE. "National Institute of Mental Health Recruitment Monitoring Policy and Clinical Trial Impact." Contemporary Clinical Trials, vol. 103, 2021, pp. 106312. |
| Ferris LM, Saloner B, Jackson K, Lyons BC, Murthy V, Kharrazi H, Latimore A, Stuart EA, Weiner JP. "Performance of a Predictive Model versus Prescription-Based Thresholds in Identifying Patients at Risk of Fatal Opioid Overdose." Substance Use & Misuse, vol. 56, no. 3, 2021, pp. 396-403. |
| Saloner B, Whitley P, LaRue L, Dawson E, Huskey A. "Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database." JAMA Network Open, vol. 4, no. 9, 2021, pp. e2123019. |
| Anderson KE, Saloner B, Eckstein J, Chaisson CE, Scholle SH, Niles L, Dy S, Alexander GC. "Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder." Medical Care, vol. 59, no. 5, 2021, pp. 393-401. |
| Anderson KE, Alexander GC, Niles L, Scholle SH, Saloner B, Dy SM. "Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder." JAMA Network Open, vol. 4, no. 4, 2021, pp. e214925. |
| Fabi RE, Saloner B, Taylor H. "State Policymaking and Stated Reasons: Prenatal Care for Undocumented Immigrants in an Era of Abortion Restriction." The Milbank Quarterly, vol. 99, no. 3, 2021, pp. 693-720. |
| Kennedy-Hendricks A, Bandara S, Merritt S, Barry CL, Saloner B. "Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision." Drug and Alcohol Dependence, vol. 226, 2021, pp. 108881. |
| Thakrar AP, Alexander GC, Saloner B. "Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021." JAMA Network Open, vol. 4, no. 12, 2021, pp. e2138807. |
| Barry CL, Saloner B. "Using Policy Tools to Improve Population Health - Combating the U.S. Opioid Crisis." New England Journal of Medicine, vol. 385, no. 23, 2021, pp. 2113-2116. |
| Krawczyk N, Williams AR, Saloner B, Cerdá M. "Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings." Journal of Substance Abuse Treatment, vol. 126, 2021, pp. 108329. |
| Saloner B, Gollust SE, Planalp C, Blewett LA. "Access and enrollment in safety net programs in the wake of COVID-19: A national cross-sectional survey." PLoS ONE, vol. 15, no. 10, 2020, pp. e0240080. |
| Alinsky RH, Hadland SE, Matson PA, Cerda M, Saloner B. "Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder." Journal of Adolescent Health, vol. 67, no. 4, 2020, pp. 542-549. |
| Alexander GC, Stoller KB, Haffajee RL, Saloner B. "An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19." Annals of Internal Medicine, vol. 173, no. 1, 2020, pp. 57-58. |
| Wen H, Soni A, Hollingsworth A, Freedman S, Benitez J, Simon K, Saloner B. "Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use." JAMA Internal Medicine, vol. 180, no. 5, 2020, pp. 753-759. |
| Wen H, Barnett ML, Saloner B. "Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders." PS, vol. 71, no. 12, 2020, pp. 1308. |
| Saloner B, Wilk AS, Levin J. "Community Health Centers and Access to Care Among Underserved Populations: A Synthesis Review." Medical Care Research and Review, vol. 77, no. 1, 2020, pp. 3-18. |
| Saloner, Brendan, Parish, Kalind, Ward, Julie A., DiLaura, Grace, Dolovich, Sharon. "COVID-19 Cases and Deaths in Federal and State Prisons." JAMA, vol. 324, no. 6, 2020, pp. 602. |
| Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. "Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons." Journal of Addiction Medicine, vol. 14, no. 5, 2020, pp. e257-e260. |
| Saloner B, Lin L, Simon K. "Geographic location of buprenorphine-waivered physicians and integration with health systems." Journal of Substance Abuse Treatment, vol. 115, 2020, pp. 108034. |
| Burns ME, Dague L, Saloner B, Voskuil K, Kim NH, Serna Borrero N, Look K. "Implementing parity for mental health and substance use treatment in Medicaid." Health Serv Res, vol. 55, no. 4, 2020, pp. 604-614. |
| McClellan C, Maclean JC, Saloner B, McGinty EE, Pesko MF. "Integrated care models and behavioral health care utilization: Quasi-experimental evidence from Medicaid health homes." Health Economics, vol. 29, no. 9, 2020, pp. 1086-1097. |
| Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, Weiner JP, Saloner B. "Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services." Addiction, vol. 115, no. 9, 2020, pp. 1683-1694. |
| Krawczyk N, Schneider KE, Eisenberg MD, Richards TM, Ferris L, Mojtabai R, Stuart EA, Casey Lyons B, Jackson K, Weiner JP, Saloner B. "Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk." Drug and Alcohol Dependence, vol. 213, 2020, pp. 107997. |
| Saloner B, Chang HY, Krawczyk N, Ferris L, Eisenberg M, Richards T, Lemke K, Schneider KE, Baier M, Weiner JP. "Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data." JAMA Psychiatry, vol. 77, no. 11, 2020, pp. 1155-1162. |
| Krawczyk N, Eisenberg M, Schneider KE, Richards TM, Lyons BC, Jackson K, Ferris L, Weiner JP, Saloner B. "Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study." Annals of Emergency Medicine, vol. 75, no. 1, 2020, pp. 1-12. |
| Wen H, Druss BG, Saloner B. "Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis." Health Affairs, vol. 39, no. 5, 2020, pp. 740-746. |
| Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. "Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework." Milbank Quarterly, vol. 98, no. 3, 2020, pp. 700-746. |
| Saloner, Brendan, Maclean, Johanna Catherine. "Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion." Health Affairs, vol. 39, no. 3, 2020, pp. 453-461. |
| Cantor J, Stein BD, Saloner B. "Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing." Journal of Addiction Medicine, vol. 14, no. 6, 2020, pp. e366-e368. |
| Chang HY, Ferris L, Eisenberg M, Krawczyk N, Schneider KE, Lemke K, Richards TM, Jackson K, Murthy VD, Weiner JP, Saloner B. "The Impact of Various Risk Assessment Time Frames on the Performance of Opioid Overdose Forecasting Models." Medical Care, vol. 58, no. 11, 2020, pp. 1013-1021. |
| Samples H, Stuart EA, Saloner B, Barry CL, Mojtabai R. "The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits." J GEN INTERN MED, vol. 35, no. 1, 2020, pp. 12-20. |
| Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. "Therapies Offered at Residential Addiction Treatment Programs in the United States." JAMA, vol. 324, no. 8, 2020, pp. 804-806. |
| Gollust SE, Saloner B, Hest R, Blewett LA. "US Adults' Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019." JAMA Network Open, vol. 3, no. 9, 2020, pp. e2023020. |
| Chang HY, Krawczyk N, Schneider KE, Ferris L, Eisenberg M, Richards TM, Lyons BC, Jackson K, Weiner JP, Saloner B. "A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients." Drug and Alcohol Dependence, vol. 201, 2019, pp. 127-133. |
| Saloner B, Dague L, Friedsam D, Voskuil K, Serna Borrero N, Burns M. "Access to Care Among Individuals Who Experienced Medicaid Lockouts After Premium Nonpayment." JAMA Network Open, vol. 2, no. 11, 2019, pp. e1914561. |
| Beetham T, Saloner B, Wakeman SE, Gaye M, Barnett ML. "Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study." Annals of Internal Medicine, vol. 171, no. 1, 2019, pp. 1-9. |
| Lin LK, Simon K, Hollingsworth A, Saloner B. "Association Between the Number of Certified Buprenorphine Prescribers and the Quantity of Buprenorphine Prescriptions: Evidence from 2015 to 2017." J GEN INTERN MED, vol. 34, no. 11, 2019, pp. 2313-2315. |
| Wen H, Saloner B, Cummings JR. "Behavioral And Other Chronic Conditions Among Adult Medicaid Enrollees: Implications For Work Requirements." Health Affairs, vol. 38, no. 4, 2019, pp. 660-667. |
| Koyawala N, Landis R, Barry CL, Stein BD, Saloner B. "Changes in Outpatient Services and Medication Use Following a Non-fatal Opioid Overdose in the West Virginia Medicaid Program." J GEN INTERN MED, vol. 34, no. 6, 2019, pp. 789-791. |
| Saloner B, Wilk AS, Wissoker D, Candon M, Hempstead K, Rhodes KV, Polsky DE, Kenney GM. "Changes in primary care access at community health centers between 2012/2013 and 2016." Health Serv Res, vol. 54, no. 1, 2019, pp. 181-186. |
| Saloner B, Barry CL. "Changes in spending and service use after a state autism insurance mandate." Autism : the international journal of research and practice, vol. 23, no. 1, 2019, pp. 167-174. |
| Chang HY, Daubresse M, Saloner B, Alexander GC. "Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder." Medical Care, vol. 57, no. 9, 2019, pp. 667-672. |
| Saloner B. "Commentary on Kertesz & Gordon (2019): Don't abandon opioid prescription control efforts, reform them." Addiction, vol. 114, no. 1, 2019, pp. 181-182. |
| Ferris LM, Saloner B, Krawczyk N, Schneider KE, Jarman MP, Jackson K, Lyons BC, Eisenberg MD, Richards TM, Lemke KW, Weiner JP. "Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data." American Journal of Preventive Medicine, vol. 57, no. 6, 2019, pp. e211-e217. |
| Saloner B, Landis R, Stein BD, Barry CL. "The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia." Health Affairs, vol. 38, no. 4, 2019, pp. 633-642. |
| Maclean JC, Saloner B. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act." Journal of Policy Analysis and Management, vol. 38, no. 2, 2019, pp. 366-93. |
| Eisenberg MD, Saloner B, Krawczyk N, Ferris L, Schneider KE, Lyons BC, Weiner JP. "Use of Opioid Overdose Deaths Reported in One State's Criminal Justice, Hospital, and Prescription Databases to Identify Risk of Opioid Fatalities." JAMA Internal Medicine, vol. 179, no. 7, 2019, pp. 980-982. |
| Saloner, Brendan, McGinty, Emma E., Beletsky, Leo, Bluthenthal, Ricky, Beyrer, Chris, Botticelli, Michael, Sherman, Susan G. "A Public Health Strategy for the Opioid Crisis." Public Health Reports®, vol. 133, no. 1_suppl, 2018, pp. 24S-34S. |
| Saloner B, Akosa Antwi Y, Maclean JC, Cook B. "Access to Health Insurance and Utilization of Substance Use Disorder Treatment: Evidence from the Affordable Care Act Dependent Coverage Provision." Health Economics, vol. 27, no. 1, 2018, pp. 50-75. |
| Roberts AW, Saloner B, Dusetzina SB. "Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015." PS, vol. 69, no. 7, 2018, pp. 832-835. |
| Saloner, Brendan, Levin, Jonathan, Chang, Hsien-Yen, Jones, Christopher, Alexander, G. Caleb. "Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion." JAMA Network Open, vol. 1, no. 4, 2018, pp. e181588. |
| Candon M, Zuckerman S, Wissoker D, Saloner B, Kenney GM, Rhodes K, Polsky D. "Declining Medicaid Fees and Primary Care Appointment Availability for New Medicaid Patients." JAMA Internal Medicine, vol. 178, no. 1, 2018, pp. 145-146. |
| Bandara SN, Samples H, Crum RM, Saloner B. "Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national survey." Journal of Substance Abuse Treatment, vol. 92, 2018, pp. 85-90. |
| Saloner B. "Medicaid Expansion, Chronic Disease, and the Next Chapter of Health Reform." J GEN INTERN MED, vol. 33, no. 3, 2018, pp. 243-244. |
| Saloner B, Hempstead K, Rhodes K, Polsky D, Pan C, Kenney GM. "Most Primary Care Physicians Provide Appointments, But Affordability Remains A Barrier For The Uninsured." Health Affairs, vol. 37, no. 4, 2018, pp. 627-634. |
| Saloner B, Stoller KB, Alexander GC. "Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment." New England Journal of Medicine, vol. 379, no. 1, 2018, pp. 4-6. |
| Bachhuber MA, Saloner B, LaRochelle M, Merlin JS, Maughan BC, Polsky D, Shaparin N, Murphy SM. "Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs." Pain Medicine, vol. 19, no. 10, 2018, pp. 1952-1960. |
| Maclean JC, Saloner B. "Substance Use Treatment Provider Behavior and Healthcare Reform: Evidence from Massachusetts." Health Economics, vol. 27, no. 1, 2018, pp. 76-101. |
| Samples H, Bandara S, Olfson M, Saloner B. "Tobacco Screening and Counseling in the U.S.: Smokers With Mental Health and Substance Use Problems." American Journal of Preventive Medicine, vol. 55, no. 4, 2018, pp. 524-532. |
| Saloner B, Bandara S, Bacchuber M, Barry CL. "An Update on "Insurance Coverage and Treatment Use Under the Affordable Care Act Among Adults With Mental and Substance Use Disorders"." PS, vol. 68, no. 3, 2017, pp. 310-311. |
| Riggs KR, Ubel PA, Saloner B. "Can Appealing to Patient Altruism Reduce Overuse of Health Care Services? An Experimental Survey." J GEN INTERN MED, vol. 32, no. 7, 2017, pp. 732-738. |
| Polsky D, Candon M, Saloner B, Wissoker D, Hempstead K, Kenney GM, Rhodes K. "Changes in Primary Care Access Between 2012 and 2016 for New Patients With Medicaid and Private Coverage." JAMA Internal Medicine, vol. 177, no. 4, 2017, pp. 588-590. |
| Saloner B, Feder KA, Krawczyk N. "Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder." JAMA Pediatrics, vol. 171, no. 8, 2017, pp. 729-731. |
| Saloner B, Bandara S, Bachhuber M, Barry CL. "Insurance Coverage and Treatment Use Under the Affordable Care Act Among Adults With Mental and Substance Use Disorders." PS, vol. 68, no. 6, 2017, pp. 542-548. |
| Bachhuber MA, Mehta PK, Faherty LJ, Saloner B. "Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment." Medical Care, vol. 55, no. 12, 2017, pp. 985-990. |
| Boudreaux MH, Gonzales G, Saloner B. "Medical Financial Burden Declined For Consumers In The Nongroup Market." Health Affairs, vol. 36, no. 5, 2017, pp. 833-837. |
| Feder KA, Krawczyk N, Saloner B. "Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder." Journal of Adolescent Health, vol. 60, no. 6, 2017, pp. 747-750. |
| Daubresse M, Saloner B, Pollack HA, Alexander GC. "Non-buprenorphine opioid utilization among patients using buprenorphine." Addiction, vol. 112, no. 6, 2017, pp. 1045-1053. |
| Krawczyk N, Picher CE, Feder KA, Saloner B. "Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine." Health Affairs, vol. 36, no. 12, 2017, pp. 2046-2053. |
| Saloner B, Daubresse M, Caleb Alexander G. "Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population." Medical Care, vol. 55, no. 7, 2017, pp. 669-676. |
| Saloner B, Bachhuber M, Barry CL. "Physicians as a Source of Medications for Nonmedical Use: Comparison of Opioid Analgesic, Stimulant, and Sedative Use in a National Sample." PS, vol. 68, no. 1, 2017, pp. 56-62. |
| Wherry LR, Saloner B. "Pregnant Immigrants: The Authors Reply." Health Affairs, vol. 36, no. 7, 2017, pp. 1346. |
| Saloner B, Cope LC, Hempstead K, Rhodes KV, Polsky D, Kenney GM. "Price Transparency in Primary Care: Can Patients Learn About Costs When Scheduling an Appointment?." J GEN INTERN MED, vol. 32, no. 7, 2017, pp. 815-821. |
| Candon M, Polsky D, Saloner B, Wissoker D, Hempstead K, Kenney GM, Rhodes K. "Primary Care Appointment Availability and the ACA Insurance Expansions." LDI issue brief, vol. 21, no. 5, 2017, pp. 1-4. |
| Krawczyk N, Feder KA, Fingerhood MI, Saloner B. "Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample." Drug and Alcohol Dependence, vol. 178, 2017, pp. 512-518. |
| Wherry LR, Fabi R, Schickedanz A, Saloner B. "State And Federal Coverage For Pregnant Immigrants: Prenatal Care Increased, No Change Detected For Infant Health." Health Affairs, vol. 36, no. 4, 2017, pp. 607-615. |
| Krawczyk N, Feder KA, Saloner B, Crum RM, Kealhofer M, Mojtabai R. "The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample." Drug and Alcohol Dependence, vol. 175, 2017, pp. 157-163. |
| Cantor J, Stoller KB, Saloner B. "The response of substance use disorder treatment providers to changes in macroeconomic conditions." Journal of Substance Abuse Treatment, vol. 81, 2017, pp. 59-65. |
| Saloner B, Sharfstein J. "A Stronger Treatment System for Opioid Use Disorders." JAMA, vol. 315, no. 20, 2016, pp. 2165-6. |
| Richards MR, Saloner B, Kenney GM, Rhodes KV, Polsky D. "Availability of New Medicaid Patient Appointments and the Role of Rural Health Clinics." Health Serv Res, vol. 51, no. 2, 2016, pp. 570-91. |
| Powell V, Saloner B, Sabik LM. "Cost Sharing in Medicaid: Assumptions, Evidence, and Future Directions." Medical Care Research and Review, vol. 73, no. 4, 2016, pp. 383-409. |
| Fabi R, Saloner B. "Covering Undocumented Immigrants - State Innovation in California." New England Journal of Medicine, vol. 375, no. 20, 2016, pp. 1913-1915. |
| Saloner B, Gresenz CR. "Health Care Experiences of Latino Children in Emerging and Traditional Destinations." Medical Care, vol. 54, no. 5, 2016, pp. 442-8. |
| Saloner B, Bandara SN, McGinty EE, Barry CL. "Justice-Involved Adults With Substance Use Disorders: Coverage Increased But Rates Of Treatment Did Not In 2014." Health Affairs, vol. 35, no. 6, 2016, pp. 1058-66. |
| Saloner B, Hochhalter S, Sabik L. "Medicaid and CHIP Premiums and Access to Care: A Systematic Review." Pediatrics, vol. 137, no. 3, 2016, pp. e20152440. |
| Saloner B, Stoller KB, Barry CL. "Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment." PS, vol. 67, no. 6, 2016, pp. 676-9. |
| Basseyn S, Saloner B, Kenney GM, Wissoker D, Polsky D, Rhodes KV. "Primary Care Appointment Availability for Medicaid Patients: Comparing Traditional and Premium Assistance Plans." Medical Care, vol. 54, no. 9, 2016, pp. 878-83. |
| Kreider AR, French B, Aysola J, Saloner B, Noonan KG, Rubin DM. "Quality of Health Insurance Coverage and Access to Care for Children in Low-Income Families." JAMA Pediatrics, vol. 170, no. 1, 2016, pp. 43-51. |
| Nathenson RA, Saloner B, Richards MR, Rhodes KV. "Spanish-Speaking Immigrants' Access to Safety Net Providers and Translation Services Across Traditional and Emerging US Destinations." The Milbank Quarterly, vol. 94, no. 4, 2016, pp. 768-799. |
| McGinty EE, Samples H, Bandara SN, Saloner B, Bachhuber MA, Barry CL. "The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014." Preventive Medicine, vol. 90, 2016, pp. 114-20. |
| Saloner B, Rhodes KV, Polsky D. "Access to primary care in England--reply." JAMA Internal Medicine, vol. 175, no. 3, 2015, pp. 467-8. |
| Saloner, Brendan, Karthikeyan, Shankar. "Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013." JAMA, vol. 314, no. 14, 2015, pp. 1515. |
| Saloner B, Polsky D, Kenney GM, Hempstead K, Rhodes KV. "Most Uninsured Adults Could Schedule Primary Care Appointments Before The ACA, But Average Price Was $160." Health Affairs, vol. 34, no. 5, 2015, pp. 773-80. |
| Friedman AB, Saloner B, Hsia RY. "No Place to Call Home--Policies to Reduce ED Use in Medicaid." New England Journal of Medicine, vol. 372, no. 25, 2015, pp. 2382-5. |
| Saloner B, McGinty EE, Barry CL. "Policy strategies to reduce youth recreational marijuana use." Pediatrics, vol. 135, no. 6, 2015, pp. 955-7. |
| Leininger LJ, Saloner B, Wherry LR. "Predicting high-cost pediatric patients: derivation and validation of a population-based model." Medical Care, vol. 53, no. 8, 2015, pp. 729-35. |
| Saloner B, Polsky D, Friedman A, Rhodes K. "Primary care appointment availability and preventive care utilization: evidence from an audit study." Medical Care Research and Review, vol. 72, no. 2, 2015, pp. 149-67. |
| Bachhuber MA, Saloner B, Barry CL. "What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply." JAMA Internal Medicine, vol. 175, no. 4, 2015, pp. 656-7. |
| Richards MR, Saloner B, Kenney GM, Rhodes K, Polsky D. "Access points for the underserved: primary care appointment availability at federally qualified health centers in 10 States." Medical Care, vol. 52, no. 9, 2014, pp. 818-25. |
| Saloner B, Lê Cook B. "An ACA provision increased treatment for young adults with possible mental illnesses relative to comparison group." Health Affairs, vol. 33, no. 8, 2014, pp. 1425-34. |
| Bachhuber MA, Saloner B, Cunningham CO, Feingold J, Barry CL. "Could Delaware's medical marijuana law reduce harms from opioid analgesics?." Delaware medical journal, vol. 86, no. 11, 2014, pp. 341-3. |
| Saloner B, Koyawala N, Kenney GM. "Coverage for low-income immigrant children increased 24.5 percent in states that expanded CHIPRA eligibility." Health Affairs, vol. 33, no. 5, 2014, pp. 832-9. |
| Saloner B, Carson N, Cook BL. "Episodes of mental health treatment among a nationally representative sample of children and adolescents." Medical Care Research and Review, vol. 71, no. 3, 2014, pp. 261-79. |
| Saloner B, Carson N, Lê Cook B. "Explaining racial/ethnic differences in adolescent substance abuse treatment completion in the United States: a decomposition analysis." Journal of Adolescent Health, vol. 54, no. 6, 2014, pp. 646-53. |
| Bachhuber MA, Saloner B, Cunningham CO, Barry CL. "Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010." JAMA Internal Medicine, vol. 174, no. 10, 2014, pp. 1668-73. |
| Saloner B, Sabik L, Sommers BD. "Pinching the poor? Medicaid cost sharing under the ACA." New England Journal of Medicine, vol. 370, no. 13, 2014, pp. 1177-80. |
| Rhodes KV, Kenney GM, Friedman AB, Saloner B, Lawson CC, Chearo D, Wissoker D, Polsky D. "Primary care access for new patients on the eve of health care reform." JAMA Internal Medicine, vol. 174, no. 6, 2014, pp. 861-9. |
| Saloner B, Matone M, Kreider AR, Budeir MS, Miller D, Huang YS, Raghavan R, French B, Rubin D. "Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health." PS, vol. 65, no. 12, 2014, pp. 1458-64. |
| Saloner B, Lê Cook B. "Alcohol and drug use: the authors reply." Health Affairs, vol. 32, no. 3, 2013, pp. 630. |
| Saloner B, Lê Cook B. "Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors." Health Affairs, vol. 32, no. 1, 2013, pp. 135-45. |
| Saloner B. "Does expanding public insurance prevent material hardship for families with children?." Medical Care Research and Review, vol. 70, no. 3, 2013, pp. 267-86. |
| Saloner B, Fullerton C, McGuire T. "The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities." Journal of Child and Adolescent Psychopharmacology, vol. 23, no. 6, 2013, pp. 401-9. |
| Gresenz CR, Blanchard JC, Timbie JW, Acosta J, Pollack CE, Ruder T, Saloner B, Benjamin-Johnson R, Weinick RM, Adamson DM, Hair B. "Behavioral Health in the District of Columbia: Assessing Need and Evaluating the Public System of Care." Rand health quarterly, vol. 2, no. 1, 2012, pp. 14. |
| Saloner B, Daniels N. "The ethics of the affordability of health insurance." Journal of Health Politics, Policy and Law, vol. 36, no. 5, 2011, pp. 815-27. |
| Daniels N, Saloner B, Gelpi AH. "Access, cost, and financing: achieving an ethical health reform." Health Affairs, vol. 28, no. 5, 2009, pp. w909-16. |
| Keating EG, Brauner MK, Galway LA, Mele JD, Burks JJ, Saloner B. "The Air Force Medical Corps' status and how its physicians respond to multiyear special pay." Military Medicine, vol. 174, no. 11, 2009, pp. 1155-62. |
| Year | Degree | Institution |
|---|---|---|
| 2012 | PhD | Harvard University |
| 2005 | BA | University of California at Berkeley |
